Valeritas Holdings, Inc. appointed Mr. Joseph Saldanha as the company's Chief Business Officer, effective January 29, 2018. In this newly created role, Mr. Saldanha will report to John Timberlake, President and Chief Executive Officer of the company. Mr. Saldanha brings more than 25 years of medical technology and pharmaceutical experience to Valeritas, including extensive diabetes expertise. Most recently, Mr. Saldanha held the position of Vice President, Marketing and Business Development at MannKind Corporation. Prior to that, he had domestic and international roles at Gulf Pharmaceuticals Industries - Julphar, Pfizer, Johnson & Johnson, Sanofi and Bristol-Myers Squibb in commercial, corporate and business development, alliance management, and manufacturing management.